Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Retinoic acid receptor responder 2 pseudogene 6 (RARRES2P6) is a **processed pseudogene** with high sequence similarity to the coding gene for retinoic acid receptor responder 2 but does not code for a functional protein[1][2][9]. Pseudogenes such as RARRES2P6 are generally regarded as non-functional genomic elements, though some may be transcribed into RNA, contributing to the regulation of related protein-coding genes by acting as competing endogenous RNAs or miRNA decoys in certain contexts[3][7]. There is currently no evidence to support a specific functional or disease role for RARRES2P6, nor is it considered a therapeutic target. Its significance lies primarily in the context of pseudogene biology and potential regulatory effects that remain largely unexplored for this specific pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinoic acid receptor responder 2 pseudogene 6 (RARRES2P6).